By Devika Patel
Knoxville, Tenn., Feb. 24 - Opko Health, Inc. completed a $20 million private placement of stock on Feb. 23, according to an 8-K filed Tuesday with the Securities and Exchange Commission.
The company sold 20 million common shares at $1.00 per share to Frost Gamma Investments Trust.
The issued shares will be restricted securities, subject to a two-year lockup, without registration rights.
Based in Miami, Opko is a specialty health care company focused on the discovery, development and commercialization of pharmaceuticals, drug delivery technologies, diagnostic systems and instruments for the treatment, diagnosis and management of ophthalmic disorders.
| Issuer: | Opko Health, Inc.
|
| Issue: | Common shares
|
| Amount: | $20 million
|
| Shares: | 20 million
|
| Price: | $1.00
|
| Warrants: | No
|
| Investor: | Frost Gamma Investments Trust
|
| Settlement date: | Feb. 23
|
| Stock symbol: | Amex: OPK
|
| Stock price: | $1.02 at close Feb. 23
|
| Market capitalization: | $209 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
